Thermo Fisher Scientific Enhances OSD Development in North America
Thermo Fisher Scientific Expands Development and Manufacturing
Thermo Fisher Scientific Inc. is making significant strides in the pharmaceutical realm by enhancing its oral solid dose (OSD) capabilities. This expansion involves a substantial investment exceeding $22 million across two key locations in North America. These strategic enhancements, particularly in Cincinnati and Bend, will foster innovation and address early development challenges that biotech and pharmaceutical companies typically encounter.
Investment in Innovative Solutions
With a focus on delivering flexible solutions, Thermo Fisher has placed a strong emphasis on its OSD teams, leveraging over 30 years of expertise in the field. Michelle Logan, the vice president and general manager for drug product in North America, emphasizes the company’s commitment to providing invaluable insights. These insights are focused on navigating regulatory landscapes and tackling potential formulation challenges faced by clients, ultimately contributing to the development of life-saving therapies.
The Importance of OSD Formulations
Oral solid dose formulations are among the most prescribed medications globally, representing a significant 84% of all medications used today. This dominance stems from their storage stability and user-friendly administration. In Cincinnati, the expansion includes dedicated R&D spaces tailored for pre-clinical early development. This allows for rapid project initiation and harnesses the latest technologies to facilitate informed decision-making, reducing the risk of costly trial-and-error approaches in drug development.
Enhancing Manufacturing Capabilities
The Bend expansion focuses on enhancing manufacturing and testing capabilities. This includes advanced methods such as spray drying, hot-melt extrusion, and dry granulation, which are essential for developing complex pharmaceutical products. Additionally, these improvements align with Thermo Fisher’s objective to accelerate pre-clinical development phases and streamline the transition to Good Manufacturing Practice (GMP) production of clinical trial materials.
Global Investment in OSD Solutions
Beyond the North American sites, Thermo Fisher is deepening its global footprint in OSD solutions. The company invests not just in Cincinnati and Bend, but also in operations in Bourgoin, Manatí, Toronto, Whitby, and Greenville. These global initiatives support Thermo Fisher's commitment to innovation, helping clients achieve over 125 new drug approvals in the past decade—a commendable achievement considering the scale of production that includes billions of tablets and capsules annually.
About Thermo Fisher Scientific
As the world leader in serving science, Thermo Fisher Scientific Inc. boasts an annual revenue exceeding $40 billion. The company’s mission revolves around enabling customers to enhance global health, safety, and cleanliness. This commitment spans various sectors, from life sciences research to diagnostics and therapy development. Through its industry-leading brands, including Thermo Scientific, Applied Biosystems, and Patheon, Thermo Fisher delivers a remarkable combination of innovative technologies and pharmaceutical services. To find out more about their extensive offerings, visit their official website.
Frequently Asked Questions
What is the purpose of Thermo Fisher Scientific's expansion?
The expansion aims to enhance the capabilities for oral solid dose development, providing innovative solutions to biotech and pharmaceutical companies.
How much has Thermo Fisher invested in this expansion?
Thermo Fisher has invested over $22 million in its Cincinnati and Bend facilities since 2021.
What are oral solid dose formulations?
OSD formulations are medications in solid form that are taken orally, and they represent a significant portion of all medications prescribed globally.
What technologies are being implemented in the expansion?
The expansion will incorporate advanced manufacturing methods such as spray drying, hot-melt extrusion, and dry granulation.
How does Thermo Fisher support drug development?
Thermo Fisher provides support in navigating regulatory challenges and overcoming formulation difficulties, facilitating the development of new drugs efficiently.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Nvidia Stock Soars Over 233%: Experts Predict Continued Growth
- Unlocking the Future: Five Reasons to Invest in SoFi Technologies
- Upcoming Week of Asian IPOs Could Reshape Market Dynamics
- The Revival of Fashion: 2024 YiXiang Gala Shines Brightly
- Elliott Management and Southwest Airlines Discuss Settlement
- QNB Group Enhances Financial Position with Successful Loan Refinancing
- Embracing Technology to Revive Jiangxi's Cultural Heritage
- Key Insights for Xiao-I Corp. Investors Amid Legal Action
- What to Expect from Apple's Financial Future Ahead
- Kamala Harris Critiques Trump Following Tragic Abortion Case
Recent Articles
- Strategic Leadership Shift at SPX Technologies Announced
- Ningbo Homelink and Danimer Unveil Innovative Compostable Cups
- Impact BioMedical Celebrates Patent for 3F™ Technology
- Exciting Expansion: Floor & Decor Opens Four New Locations
- Biodexa Pharmaceuticals Reveals Detailed Interim Results
- Upcoming Dexcom Q3 Earnings Conference Call Scheduled
- Fortress Biotech Engages Investors in Upcoming Conferences
- CSG Systems to Host Earnings Call for Q3 2024 Insights
- Reborn Coffee Expands Global Footprint with New Thailand Locations
- ColoBarn Partners with IvedaAI™ to Elevate Security Standards
- Yoshiharu Global Co. Expands into Korean BBQ Market
- Tempus and Takeda Collaborate for Enhanced Cancer Treatment Insights
- EXL Unveils Advanced LLM for Insurance Powered by NVIDIA
- OSI Systems Secures $27 Million for Cargo Inspection Service
- Stellantis Celebrates Exceptional Suppliers at Annual Awards
- Wearables Market Set for Growth with Varied Category Trends
- AITX Expands RIO™ Security Solutions with New Order
- Forge Global Introduces Innovative Forge Price for Investments
- Rising Apartment Supply Leads to Decrease in Asking Rents
- Alivia Analytics Welcomes Manny Fernandez as SVP of Government Solutions
- Upcoming Auction Insights for FirstEnergy's Default Service Program
- Addressing Manager Stress: A Call for Workplace Transformation
- Guggenheim Treasury Service's Groundbreaking Digital Commercial Paper
- LightPath Technologies Receives Major Defense Production Order
- cove.tool's New Book Aims at Transforming Built Environment
- AdTech Holding Achieves Great Place to Work Certification
- Amerant Bancorp Inc. Unveils Attractive Stock Offering Strategy
- Essential Permitting Tips for Homeowners After Hurricane Helene
- Princeton TMX Recognized as a Top Innovator in FreightTech
- SysAid Celebrates Recognition in Gartner Hype Cycle 2024 Reports
- Maximizing Returns: How to Generate Income from Costco Stock
- Finvi Partners with Divinity Software to Enhance Velosidy Efforts
- GITAI USA Moves to Larger HQ, Boosts Space Robotics Production
- Insights from CNBC's Final Trades: Key Stock Picks
- Unlocking the Mysteries of Precognition: Insights from Jon Taylor
- Discover These 3 Undervalued Materials Stocks to Watch
- Cascadia Windows & Doors Sets New Standards with EPDs
- Gulf Energy Information Joins Forces with Chempute Software
- Delaware LIVE News Enhances Structure for Local Coverage Growth
- Revolutionizing Financial Education with Vanguard AI 4.0
- Raising Awareness on Foster Care Housing Challenges Nationwide
- Engaging Discussions Await at 2025 CONNECTIONS™ Conferences
- Short Shorts Film Festival & Asia 2024 Autumn Screening Launch
- Empowering Women: SeeHer's Groundbreaking Campaign Launch
- Looma Secures $10 Million Funding to Enhance Store Media
- Researchers Discover New Drug Potential to Combat Aging
- AbbVie Reports Positive Phase 3 Trial Results for Tavapadon
- NaaS Technology Forms Strategic Alliance with IM Motors for EV Charging
- PTC Therapeutics Advances Huntington's Treatment with FDA's Support
- Mizuho Securities Projects Strong Performance for Accenture